<DOC>
	<DOCNO>NCT00352768</DOCNO>
	<brief_summary>This study verify efficacy fluvoxamine maleate give 10 week treatment child adolescents obsessive-compulsive disorder</brief_summary>
	<brief_title>Fluvoxamine Maleate Treatment Obsessive-Compulsive Disorder : A Post-marketing Clinical Study Children Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Fluvoxamine</mesh_term>
	<criteria>Inclusion Criteria Have minimum total score 16 JCYBOCS , Weight within standard weight Â± 2S.D . base standard weight age School Health Statistical Survey Exclusion Criteria Have follow predominant psychiatric diagnosis Schizophrenia Have previously treat fluvoxamine maleate</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Fluvoxamine Maleate</keyword>
	<keyword>OCD</keyword>
	<keyword>Children Adolescents</keyword>
</DOC>